Home

Melbourne researchers have identified a gene mutation in the leukaemia cells of patients who become resistant to venetoclax, a discovery which can be used to identify those at-risk of relapse and help improve outcomes from this breakthrough blood cancer drug.

Researchers at Peter Mac have discovered a genetic mutation which may lead to a new combination drug treatment to be tested in forthcoming clinical trials in Mantle Cell Lymphoma (MCL) patients.

Peter Mac was delighted to host The Hon. Greg Hunt MP, Minister for Health, to announce important changes to the PBS which will provide or improve subsidised access to life-changing cancer drugs.